Yoshimitsu Yura

7PUBLICATIONS
42CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursPredictive and prognostic markersMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2026
Empagliflozin Attenuates Cardiac Fibrosis by Suppressing Fibroblast-Mediated C-C Motif Chemokine Ligand 2 Expression.

Eri Nakai, Keita Horitani, Hayato Ogawa

|Aug 06, 2025
Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease.

Yohei Arai, Nicholas W Chavkin, Yuka Arai

|Jan 31, 2025
Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice.

Kunihiko Takahara, Noriyuki Ouchi, Tomonobu Takikawa

|Nov 18, 2024
ALPK2 prevents cardiac diastolic dysfunction in heart failure with preserved ejection fraction.

Tatsuya Yoshida, Satoya Yoshida, Kohei Inukai

|Sep 05, 2024
Experimental TET2 Clonal Hematopoiesis Predisposes to Renal Hypertension Through an Inflammasome-Mediated Mechanism.

Ariel H Polizio, Lucila Marino, Kyung-Duk Min

|Jul 10, 2024
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis.

Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura

Pageof 2

Frequent Collaborators

3 joint publications

Emiri Miura-Yura

3 joint publications

Kenneth Walsh

2 joint publications

Soichi Sano

2 joint publications

Takahiro Okumura